Wall Street Analysts Believe Cogent Biosciences (COGT) Could Rally 224.37%: Here's is How to Trade

Core Viewpoint - Cogent Biosciences, Inc. (COGT) shows significant upside potential with a mean price target of $16.64, indicating a 224.4% increase from the current price of $5.13 [1] Price Targets and Analyst Consensus - The average of 11 short-term price targets ranges from a low of $7 to a high of $24, with a standard deviation of $5.28, suggesting variability in analyst estimates [2] - The lowest estimate indicates a 36.5% increase, while the most optimistic estimate points to a 367.8% upside [2] - A low standard deviation indicates a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Optimism - Analysts are optimistic about COGT's earnings prospects, as indicated by a positive trend in earnings estimate revisions [4][11] - The Zacks Consensus Estimate for the current year has increased by 3% over the past month, with one estimate going higher and no negative revisions [12] - COGT holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13]